U.S. flag

An official website of the United States government

NM_000359.3(TGM1):c.1166G>A (p.Arg389His) AND not provided

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Aug 24, 2021
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000523198.4

Allele description

NM_000359.3(TGM1):c.1166G>A (p.Arg389His)

Gene:
TGM1:transglutaminase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
14q12
Genomic location:
Preferred name:
NM_000359.3(TGM1):c.1166G>A (p.Arg389His)
Other names:
R388H
HGVS:
  • NC_000014.9:g.24258667C>T
  • NG_007150.1:g.9500G>A
  • NM_000359.3:c.1166G>AMANE SELECT
  • NP_000350.1:p.Arg389His
  • NC_000014.8:g.24727873C>T
  • NM_000359.2:c.1166G>A
  • P22735:p.Arg389His
Protein change:
R389H; ARG388HIS
Links:
UniProtKB: P22735#VAR_015222; OMIM: 190195.0011; dbSNP: rs121918723
NCBI 1000 Genomes Browser:
rs121918723
Molecular consequence:
  • NM_000359.3:c.1166G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000616892GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Pathogenic
(Jul 19, 2018)
germlineclinical testing

Citation Link,

SCV002239745Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Aug 24, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From GeneDx, SCV000616892.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The R389H pathogenic variant in the TGM1 gene has been reported previously either in combination with another TGM1 variant or in the homozygous state in individuals with autosomal recessive congenital ichthyosis (Akiyama et al., 2001; Esposito et al., 2014). This variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). The R389H variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. However, this substitution occurs at a position in the core domain (Akiyama et al., 2001) that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. A different missense variant in the same codon (R389P) has also been reported in association with congenital ichthyosis (Schevchenko et al., 2000; Oji et al., 2006), supporting the functional importance of this region of the protein. We interpret R389H as a pathogenic variant.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Invitae, SCV002239745.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Aug 23, 2022